Replies to post #132164 on Biotech Values

[DewDiligence]

PSI-938 as an asset should be valued at about $3B of the deal’s overall price.

Do you seriously think that a hypothetical company with PSI-938 as its lead drug would have fetched $3B in a buyout? Not even close, IMHO.